Could a Dolutegravir-Based Antiretroviral Therapy Lead to Clinical Obesity? A Retrospective Cohort Study Conducted at Hawassa University Comprehensive Specialized Hospital in Hawassa, Sidama, Ethiopia

Table 4

Factors influencing weight change variations among HIV/AIDS patients on ART enrolled in the ART Clinic at Hawassa University Comprehensive Specialized Hospital in March 2021.

	Total (n) = 422	TLD (N) = 211	TLE (n) = 211	value
Age in year(mean ± SD)	41.44 ± 10.4	40.28 ± 9.93	42.60 ± 10.75	<0.001
Initial weight in kg (mean ± SD)	57.10 ± 7.86	56.85 ± 7.83	57.38 ± 7.96	<0.001
Current weight in kg (mean ± SD)	60.17 ± 7.27	60.78 ± 7.51	59.57 ± 7.1	<0.001
Weight difference, kg (mean ± SD)	3.07 ± 2.36	3.882 ± .21	2.2559 ± 2.39	<0.001
Initial BMI, kg/m^2 (mean ± SD)	20.79 ± 1.94	20.62 ± 2	20.96 ± 1.88	<0.001
Current BMI, kg/m2 (mean ± SD)	21.93 ± 1.80	22.06 ± 1.9	21.80 ± 1.71	<0.001
BMI difference, kg/m^2 (mean ± SD)	1.16 ± .96	1.48 ± .86	.8389 ± .95	<0.001